MedPath

Evaluating Acceptance and Commitment Therapy based group treatment for trauma symptom management and overall wellbeing in a residential Alcohol and Other Drug treatment facility.

Not Applicable
Recruiting
Conditions
Alcohol and Other Drug Dependence
Post Traumatic Stress Disorder
Mental Health - Other mental health disorders
Mental Health - Addiction
Registration Number
ACTRN12614000585628
Lead Sponsor
etwork of Alcohol and other Drugs Agencies (NADA)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

All current clients at We Help Ourselves (WHOS) 'New Beginnings' women's AOD treatment program.

Exclusion Criteria

Mental health screenings are carried out as standard practise at New Beginnings to determine eligibility for treatment. Prescreening questionnaires include a severity of dependence scale, frequency and pattern of drug and alcohol use based on the BTOM and ATTOM, Kessler 10, and WHO QoL-8 Quality of life scale.
Women are not eligible for admission to New Beginnings if they demonstrate florid psychosis, risk of suicide, or if their mental health is deemed too unstable by our mental health nurse.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A reduction in PTSD symptoms, based on the PTSD Symptom Checklist for Civilians (PCL-C).[Baseline: Calculated by averaging weekly measurements for two months of AOD treatment as usual, until commencing the proposed treatment.<br>One week following treatment, and at one month follow up.];Wellbeing, measured by the World Health Organisation 8-point Quality of Life Scale (EUROHIS-QOL 8)[Baseline: Calculated by averaging weekly measurements for two months of AOD treatment as usual, until commencing the proposed treatment.<br>One week following treatment, and at one month follow up.];Psychological Distress as measured by the Kessler Psychological Distress Scale (K10+)[Baseline: Calculated by averaging weekly measurements for two months of AOD treatment as usual, until commencing the proposed treatment.<br>One week following treatment, and at one month follow up.]
Secondary Outcome Measures
NameTimeMethod
nil[nil]
© Copyright 2025. All Rights Reserved by MedPath